SANOFI

A ~

pharmaceutical for the treatment of insomnia;A TILDE;Color is not claimed as a feature of the mark.;

A2BLOC

pharmaceutical preparations for the prevention and treatment of cardiovascular troubles;A 2 BLOCK;

ABELIA

PHARMACEUTICAL PREPARATIONS USED FOR THE TREATMENT OF HORMONAL DISORDERS AND IN GYNECOLOGY, ADHESIVE BANDAGES FOR TRANSDERMAL ADMINISTERING OF PHARMACEUTICAL PRODUCTS;CONTAINERS FOR THE APPLYING OF MEDICINES INCLUDING CONTAINERS FOR TRANSDERMAL DIFFUSION;

ABELIA

pharmaceutical preparations used for the treatment of hormonal disorders; adhesive bandages for transdermal administering of pharmaceutical products;containers for the applying of medicines, namely, containers for transdermal diffusion;

ABROVEL

pharmaceutical products for the prevention and treatment of cardiovascular troubles;

ACCELRARE

Recorded computer programs for assistance in diagnosis of rare diseases and for accelerating patient management; recorded computer software for use in analysis of patient data in the field of health of rare diseases;Diagnostic aids for medical use, namely, diagnostic apparatus for the detection of rare diseases;Design and development of computer software for data collection, selection, processing, transmission, analysis, comparison and storage for medical diagnosis in the field of rare diseases;

ACCÈS AU MÉDICAMENT ACCESS TO MEDICINES

TRAINING COURSES INTENDED FOR HEALTH PROFESSIONALS AND PUBLIC HEALTH OFFICIALS IN THE FIELDS OF HEALTHCARE, PHARMACEUTICALS AND MEDICAL DEVELOPMENTS; EDUCATION, NAMELY, PROVIDING CLASSES, CONFERENCES, DISCUSSION GROUPS, SEMINARS AND LECTURES IN THE MEDICAL AND PHARMACEUTICAL FIELD RELATING TO TREATMENT OF CERTAIN DISEASES, IN PARTICULAR MALARIA, TUBERCULOSIS, SLEEPING SICKNESS, LEISHMANIASIS OR EPILEPSY; ORGANIZATION OF SEMINARS, WORKING GROUPS, CONVENTIONS, DISCUSSION FORUMS IN THE MEDICAL AND PHARMACEUTICAL FIELD; PRODUCTION AND PUBLICATION, ON ALL TYPES OF MEDIA, NAMELY, NEWSPAPERS, MAGAZINES, PERIODICAL REVIEWS, PAMPHLETS, BOOKS, HANDBOOKS IN THE MEDICAL AND PHARMACEUTICAL FIELD; TRAINING COURSES IN THE FIELD OF HEALTHCARE, PHARMACEUTICALS AND MEDICAL DEVELOPMENTS;ACCÈS AU MÉDICAMENT ACCESS TO MEDICINES V V;The English translation of ACCÈSS AU MÉDICAMENT in the mark is ACCESS TO MEDICINES.;The mark consists of the colors red, maroon, and blue, with the color red appearing in the wording ACCÈS AU MÉDICAMENT, the color maroon appearing in the wording ACCESS TO MEDICINES, the color red appearing in the design element of the large inverted V and the color blue appearing in the small V design element.;INFORMATION AND DATA PROCESSING DEVICES, NAMELY, CENTRAL PROCESSING UNITS FOR PROCESSING INFORMATION, DATA, SOUND OR IMAGES; DIGITAL DATA MEDIA, NAMELY, PRE-RECORDED AUDIO CASSETTES, PRE-RECORDED VIDEO CASSETTES AND PRE-RECORDED DIGITAL COMPACT DISCS FEATURING INFORMATION REGARDING HEALTHCARE, PHARMACEUTICALS AND MEDICAL DEVELOPMENTS; AUDIO CASSETTES; VIDEO CASSETTES; DIGITAL COMPACT DISCS; COMPUTER SOFTWARE FOR DATABASE MANAGEMENT IN THE FIELDS OF HEALTHCARE, PHARMACEUTICALS AND MEDICAL DEVELOPMENTS;Line 10, after digital data media, the following NAMELY, PRE-RECORDED AUDIO CASSETTES, PRE-RECORDED VIDEO CASSETTES AND PRE-RECORDED DIGITAL COMPACT DISCS FEATURING INFORMATION REGARDING HEALTHCARE, PHARMACEUTICALS AND MEDICAL DEVELOPMENTS should be inserted.;PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF CERTAIN DISEASES, IN PARTICULAR MALARIA, TUBERCULOSIS, SLEEPING SICKNESS, LEISHMANIASIS OR EPILEPSY;PAPER, CARDBOARD, PAPER OR CARDBOARD GOODS, NAMELY, CARDBOARD BOXES, CARTONS; PAPER BAGS; ENVELOPES, SMALL BAGS OF PAPER; PRINTED MATTER, NAMELY, NEWSPAPERS, MAGAZINES, PERIODICAL REVIEWS, PAMPHLETS, BOOKS, BIBLIOGRAPHIES; INSTRUCTIONAL AND TEACHING MATERIALS ALL IN THE FIELDS OF HEALTHCARE, PHARMACEUTICALS AND MEDICAL DEVELOPMENTS;COMMUNICATIONS BY COMPUTER TERMINALS; TRANSMISSION VIA COMPUTER COMMUNICATIONS OF INFORMATION, DOCUMENTS, DATA FILES;FINANCIAL SERVICES IN THE INDUSTRIAL AND MEDICAL RESEARCH FIELDS, NAMELY, FUND-RAISING SERVICES FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT;The color(s) red, maroon and blue is/are claimed as a feature of the mark.;ASSISTANCE AND SUPPORT SERVICES PROVIDED IN THE CONTEXT OF THE ACCESS TO MEDICINES PROGRAM, NAMELY, DISSEMINATION OF ADVERTISING MATERIAL; DISTRIBUTORSHIPS IN THE FIELD OF PRINTED MATERIAL, NAMELY, NEWSPAPERS, MAGAZINE, PERIODICALS, PAMPHLETS, BOOKS, BIBLIOGRAPHIES, INSTRUCTIONAL AND TEACHING MATERIALS ALL IN THE FIELDS OF HEALTHCARE, PHARMACEUTICALS AND MEDICAL DEVELOPMENTS; SUPPLY CHAIN MANAGEMENT IN THE FIELD OF PHARMACEUTICAL PRODUCTS AND PREPARATIONS;HEALTH CARE SERVICES, NAMELY, DISEASE MANAGEMENT PROGRAMS FOR TUBERCULOSIS, SLEEPING SICKNESS, LEISHMANIASIS OR EPILEPSY; MEDICAL ADVISORY SERVICES FOR TRAVELERS CONCERNING LOCAL MEDICAL RISKS; ASSISTANCE AND SUPPORT SERVICES PROVIDED IN THE CONTEXT OF THE ACCESS TO MEDICINES PROGRAMS, NAMELY, MEDICAL AND PHARMACEUTICAL INFORMATION SERVICES; INFORMATION REGARDING MEDICINE FOR HEALTH PROFESSIONALS AND PUBLIC HEALTH OFFICIALS; INFORMATION SERVICES IN THE MEDICAL AND PHARMACEUTICAL FIELDS;MEDICAMENT AND MEDICINES;RESEARCH AND DEVELOPMENT SERVICES IN THE MEDICAL AND PHARMACEUTICAL FIELDS RELATING TO THE TREATMENT OF CERTAIN DISEASES, NAMELY, MALARIA, TUBERCULOSIS, SLEEPING SICKNESS, LEISHMANIASIS OR EPILEPSY; CONDUCTING MEDICAL STUDIES RELATING TO MALARIA, TUBERCULOSIS, SLEEPING SICKNESS, LEISHMANIASIS OR EPILEPSY; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES, NAMELY, ASSISTANCE AND SUPPORT SERVICES PROVIDED IN THE FRAMEWORK OF THE ACCESS TO MEDICINES PROGRAM, NAMELY, DEVELOPING NEW TREATMENTS AND DRUG FORMULATIONS AND ASSOCIATIONS INTENDED TO BENEFIT PATIENTS AND THOSE INVOLVED IN INTERNATIONAL HEALTH WORK;

ACOMPLIA

Pharmaceutical preparations; medicines for, in particular, treatment of obesity, tobacco withdrawal and for the prevention of cardiovascular diseases; preparations and dietetic beverages for medical use; medicinal infusions;The color(s) blue is/are claimed as a feature of the mark.;

ACORV

Pharmaceutical preparations and antibodies; diagnostic and therapeutic products for medical and/or veterinary use; biological cultures for medical and/or veterinary use;Chemical products used in the manufacture of pharmaceutical products; biological compounds used in the manufacture of pharmaceutical products, namely, antibodies;Scientific research and laboratory research services in the field of biotechnology; biotechnical research; advice in the field of biotechnology, bacteriological research, biological research, research and development of new pharmaceutical products and components for third parties, clinical trials, chemical analysis and research services, medical research, pharmaceutical research services;

ACT ON 3'S

ACT ON THREE'S;Providing medical information for doctors, patients, and caregivers in the field of diabetes;

ACT ON THREES

Providing medical information for doctors, patients, and caregivers in the field of diabetes;

ACTILOG

Anti-diabetic preparations;

ACTURO

Pharmaceutical preparations for the treatment of benign prostate hyperplasia (BPH); pharmaceutical preparations for the treatment of urological diseases and conditions; pharmaceutical preparations for the treatment of enlarged prostate;The wording ACTURO has no meaning in a foreign language.;

ADAPTSTAR

In the statement, Sanofi-Aventis should be deleted, and Sanofi (corporation) 174, avenue de France, Paris, France75013 should be inserted.;ADAPT STAR;insulin injector pens sold empty;

ADJETTRO

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases, infectious diseases, and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases;The wording ADJETTRO has no meaning in a foreign language.;

ADJETTRO

local anesthetics;

ADJICIDO

pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections;The wording ADJICIDO has no meaning in a foreign language.;

ADJISI

pharmaceutical preparations for the prevention and treatment of cardiovascular diseases, infectious diseases, and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases;

ADJONEY

pharmaceutical preparations for the prevention and treatment of cardiovascular diseases, infectious diseases, and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases;

ADJONEY

local anesthetics;

ADLYXEN

Anti-diabetic preparations;

ADLYXIN

Anti-diabetic preparations;

ADLYXINE

Anti-diabetic preparations;

ADMELOG

Anti-diabetic preparations;

ADMELOG

The mark consists of a circular design, half in purple and half in yellow. The purple half has streaks coming from the left side of the circle, giving the impression of motion. To the right of this design is the wording ADMELOG in purple stylized font.;Anti-diabetic preparations;The color(s) purple and yellow is/are claimed as a feature of the mark.;